November 2012 FDA Recall Drug by West-ward Pharmaceutical Corp.
D-132-2013 - Presence of Foreign Substance

This Class II drug recall was voluntarily initiated by West-ward Pharmaceutical Corp. on November 30, 2012 for the product Drug. The FDA reported the reason for recall as presence of foreign substance. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-132-2013

Reason for Recall
Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.
Initiated
11-30-2012
Reported
01-30-2013
Quantity
43,478 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
West-ward Pharmaceutical Corp.
Nationwide and Puerto Rico
Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.

Batch or Lot Expiration Information

Lot# : 69392A, 69393A, 69394A, 69395A, 69396A, 69397A , Exp 09/15; 69495A, 69496A, 69497A, 69498A, 69524A, 69525A, Exp 10/15